Tags: cancermetforminmyeloid leukemiaburn scarsmarjolin's ulcer
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | 1453746 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | UCL study suggests changes to improve MRI scans for prostate cancer - about 1 year ago | |
2 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Male Fertility Problems in the Family Linked to Cancer Risk - 9 months ago TULSA Effective in Controlling Prostate Cancer Long-Term - 12 months ago | |
3 | Frank Dalleres City A.M. Sports Editor at City A.M. London | ||
4 | The Conversation Science Alert Science news. Official account. Australia | ||
5 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - about 1 month ago | |
6 | Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England | STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 2 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - about 1 year ago | |
7 | Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. | ||
8 | Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed | ||
9 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
10 | Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. |